|Articles|June 21, 2023
Mass Spectrometry Imaging: Top 8 benefits in oncology drug discovery and development
Author(s) Pyxant
Mass spectrometry imaging (MSI) is beneficial in early development and murine models across many therapeutic areas. This technique is especially suited for oncology due to the availability of tissue.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
Women in STEM: Early Phase Drug Development
4
PharmTech Weekly Roundup - February 6, 2026
5